Avalyn Pharma (AVLN) stock will be in focus as the company files for a Nasdaq IPO to fund clinical studies for its inhaled drugs for pulmonary fibrosis. Read more here.
You are being redirected to the original discussion. Please continue if you want to read the full post.
Continue to original articleYou will be redirected in 3 seconds.